
Sign up to save your podcasts
Or


This subgroup analysis from the MASTER-DAPT trial demonstrates that in high-bleeding risk patients with acute or recent myocardial infarction it is safe to stop DAPT 1 month after stenting and that this strategy provides a reduction in bleeding risk.
In this interview, Pieter C. Smits MD, PhD, FESC and Sidney C. Smith Jr. MD, MACC, with Jeffrey Hsu MD, PhD, discuss a recent piece from JACC: Abbreviated Antiplatelet Therapy after Coronary Stenting in Patients with Myocardial Infarction at High Bleeding Risk.
Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
By American College of Cardiology3.8
5454 ratings
This subgroup analysis from the MASTER-DAPT trial demonstrates that in high-bleeding risk patients with acute or recent myocardial infarction it is safe to stop DAPT 1 month after stenting and that this strategy provides a reduction in bleeding risk.
In this interview, Pieter C. Smits MD, PhD, FESC and Sidney C. Smith Jr. MD, MACC, with Jeffrey Hsu MD, PhD, discuss a recent piece from JACC: Abbreviated Antiplatelet Therapy after Coronary Stenting in Patients with Myocardial Infarction at High Bleeding Risk.
Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

137 Listeners

320 Listeners

497 Listeners

169 Listeners

885 Listeners

290 Listeners

140 Listeners

1,156 Listeners

41 Listeners

195 Listeners

90 Listeners

364 Listeners

430 Listeners

371 Listeners

32 Listeners